We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Allergan Cuts A Few State Claims In Restasis MDL

Law360 (November 14, 2018, 3:50 PM EST) -- Health benefits providers that refunded members for the cost of Allergan’s dry-eye medication Restasis will be able to move forward on the majority of the state law claims the drugmaker wanted...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.